Argos Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Argos Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 101% to $1,899,398. The net income raised on -$40,577,510 and profit margin reached -2136%. Total operating expenses were $64,357,955.
Profit Margin
| 2014 | 1.97M | -53.30M | -2700.38% |
|---|---|---|---|
| 2015 | 518.32K | -74.78M | -14428.77% |
| 2016 | 945.46K | -53.02M | -5608.66% |
| 2017 | 1.89M | -40.57M | -2136.34% |
ARGS Income Statement (2014 – 2017)
| 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 1.89M | 945.46K | 518.32K | 1.97M |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 1.89M | 945.46K | 518.32K | 1.97M |
Operating exp. | ||||
Research and development | 21.65M | 38.30M | 62.05M | 45.49M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 64.35M | 53.25M | 73.06M | 54.09M |
Operating income | -62.45M | -52.30M | -72.54M | -52.12M |
Other income (expenses), net | 21.88M | -717.89K | -2.25M | -1.20M |
Income before tax | -40.56M | -53.02M | -74.80M | -53.32M |
Income tax expense | 23.19M | 1.05M | 9.17K | -80.41K |
Net income | -40.57M | -53.02M | -74.78M | -53.30M |
Earnings per share | ||||
Basic EPS | -4.22 | -5.52 | -7.78 | -5.55 |
Diluted EPS | -13.45 | -1.66 | -3.66 | -3.07 |
| Data source | Data source | Data source | Data source |